Image

    Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?

    February 2022 in “ Journal of Cosmetic Dermatology ”
    Sema Koç Yıldırım, Ece Erbağcı, Neslihan Demirel Öğüt
    Studysummary This study found that patients with telogen effluvium had a higher rate of acute hair loss and lower monocyte counts if they had contracted COVID-19 prior to hair loss onset.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 18

    1. Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium? Journal of Cosmetic Dermatology · 2022
    2. COVID-19 Induced Telogen Effluvium Dermatologic Therapy · 2021
    3. Characteristics of Telogen Effluvium in COVID-19 in Western Iran (2020) Anais Brasileiros De Dermatologia · 2021
    4. COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium Irish Journal of Medical Science (1971 -) · 2021
    5. Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management JAAD International · 2021
    6. Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium Journal of The American Academy of Dermatology · 2021
    7. Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients Experimental Dermatology · 2021
    8. Race, Ethnicity, and Comorbidities Are Critical Factors in the Diagnosis of Telogen Effluvium During the COVID-19 Pandemic Journal of The American Academy of Dermatology · 2021
    9. Telogen Effluvium Associated with COVID-19 Infection Dermatologic Therapy · 2021
    10. Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms Skin appendage disorders · 2021
    11. A Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19 Journal of The American Academy of Dermatology · 2020
    12. SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study Journal of the European Academy of Dermatology and Venereology · 2020
    13. Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience Dermatologic Therapy · 2020
    14. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019 Open Forum Infectious Diseases · 2020
    15. Relative Changes in the Pattern of Diseases Presenting in Dermatology Outpatient Clinic in the Era of the COVID-19 Pandemic Dermatologic Therapy · 2020
    16. Telogen Effluvium: A Review of the Literature Cureus · 2020
    17. Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature Drugs - Real World Outcomes · 2016
    18. Interleukin-1β Is Differentially Expressed by Human Dermal Papilla Cells in Response to PKC Activation and Is a Potent Inhibitor of Human Hair Follicle Growth in Organ Culture Journal of interferon & cytokine research · 1997